Chembio Diagnostics to Report Second Quarter 2020 Financial Results on August 6, 2020
July 23 2020 - 4:10PM
Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care
diagnostics company focused on infectious diseases, announced today
that it will release financial results for the second quarter 2020
after the close of trading on Thursday, August 6, 2020.
The company’s management team will host a
corresponding conference call beginning at 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so
by dialing 844-369-8770 from the US or 862-298-0840 from outside
the US or by accessing
www.chembio.com/investors/calendar-of-events/. A replay of the call
will be available by dialing 877-481-4010 from the US or
919-882-2331 from outside the US (using passcode 35830) or by
accessing www.chembio.com/investors/calendar-of-events/.
About Chembio
DiagnosticsChembio is a leading point-of-care diagnostics
company focused on detecting and diagnosing infectious diseases,
including COVID-19, sexually transmitted disease, and fever and
tropical disease. The company’s proprietary DPP technology
platform, which uses a small drop of blood from the fingertip or
alternative sample types, provides high-quality, cost-effective
results in approximately 15 minutes. Coupled with Chembio’s
extensive scientific expertise, its novel DPP technology offers
broad market applications beyond infectious disease. Chembio’s
products are sold globally, directly and through distributors, to
hospitals and clinics, physician offices, clinical laboratories,
public health organizations, government agencies, and consumers.
Learn more at www.chembio.com.
DPP is Chembio’s registered trademark. For
convenience, this trademark appears in this release without ®
symbols, but that practice does not mean that Chembio will not
assert, to the fullest extent under applicable law, its rights to
the trademark.
Investor contact:Philip
TaylorGilmartin Group(415) 937-5406investor@chembio.co
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Chembio Diagnostics (NASDAQ:CEMI)
Historical Stock Chart
From Apr 2023 to Apr 2024